首页 | 本学科首页   官方微博 | 高级检索  
     

不同转移潜能人肝癌细胞株趋化因子受体谱差异表达
引用本文:薛同春,陈荣新,叶胜龙,孙瑞霞,陈洁,汤钊猷. 不同转移潜能人肝癌细胞株趋化因子受体谱差异表达[J]. 中华肝脏病杂志, 2007, 15(4): 261-265
作者姓名:薛同春  陈荣新  叶胜龙  孙瑞霞  陈洁  汤钊猷
作者单位:200032,上海,复旦大学中山医院肝癌研究所、癌变与侵袭原理教育部重点实验室
基金项目:国家重点基础研究项目(2004CB518708);复旦大学“211”工程肿瘤学科建设项目(校批字[2003]257号)
摘    要:目的对比观察不同转移潜能人肝癌细胞株趋化因子受体谱差异性表达。方法Pre- mier软件设计18对趋化因子受体引物,RT-PCR分析SMMC-7721、MHCC97-L、MHCC97-H和HCCLM6细胞侵袭转移潜能逐渐增强的人肝癌细胞株趋化因子受体谱。结果4组不同转移潜能细胞株趋化因子受体表达谱存在明显差异(P<0.01),其中CCR10、CXCR4、CXCR6表达随转移潜能增加逐渐降低。HCCLM6表达谱中CCR3、CCR4、CCR10、CCR12及XCR1比SMMC-7721表达明显降低甚至缺失(P<0.01),而CXCR1(P=0.006)、CXCR5(P=0.003)表达高于低转移潜能组SMMC-7721。MHCC97-H和MHCC97-L比较,除CXCR2、CXCR6、XCR1外差异均有统计学意义,其中CCR1(P=0.002)、CCR2(P=0.004)、CCR5(P=0.046)表达高于MHCC97- L。CXCR4在模板减量时只能在SMMC-7721组检测到。结论高低转移潜能肝癌细胞株趋化因子受体表达在mRNA水平存在差异性表达,与肝癌细胞株差异性转移潜能相关。

关 键 词:  肝细胞 受体  趋化因子 转移  肿瘤 聚合酶链反应  逆转录
修稿时间:2006-05-15

Different expressions of chemokine receptors in human hepatocellular carcinoma cell lines with different metastatic potentials
XUE Tong-chun,CHEN Rong-xin,YE Sheng-long,SUN Rei-xia,CHEN Jie,TANG Zhao-you. Different expressions of chemokine receptors in human hepatocellular carcinoma cell lines with different metastatic potentials[J]. Chinese journal of hepatology, 2007, 15(4): 261-265
Authors:XUE Tong-chun  CHEN Rong-xin  YE Sheng-long  SUN Rei-xia  CHEN Jie  TANG Zhao-you
Affiliation:Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai 200032, China
Abstract:OBJECTIVE: To compare different expression profiles of all known chemokine receptors in human hepatocellular carcinoma (HCC) cell lines with different metastasis potentials. METHODS: Eighteen pairs of chemokine receptor primers were designed using Premier software. Expression profiles of the 18 chemokine receptors on four HCC cell lines of lower to higher potentials of metastasis (SMMC-7721, MHCC97-L, MHCC97-H and HCCLM6) were analyzed by RT-PCR. Expression of CXCR4 was detected by RT-PCR. RESULTS: Expression profiles of chemokine receptors on four HCC cell lines with different metastatic potentials had significant differences (P < 0.01), in which CCR10, CXCR4 and CXCR6 expressions decreased gradually as the metastatic potential of the cell lines increased. The expressions of CCR3, CCR4, CCR10, CCR12 and XCR1 on HCCLM6 were significantly reduced compared with SMMC-7721 (P < 0.01), whereas the expressions of CXCR1 (P = 0.006) and CXCR5 (P = 0.003) exceeded that of SMMC-7721. Except for CXCR2, CXCR6 and XCR1, most of chemokine receptors on MHCC97-H were expressed differently compared with MHCC97-L (P < 0.05), in which expressions of CCR1 (P = 0.002), CCR2 (P = 0.004) and CCR5 (P = 0.046) exceeded MHCC97-L. CXCR4 was detected only on the positive controls and SMMC-7721 when the template of total RNA was reduced one-half in RT-PCR. CONCLUSION: Chemokine receptors are expressed very differently at mRNA level on HCC cell lines with different metastatic potentials. The different profiles of chemokine receptors in tumor microenvironment and the function of CXCR4 in HCC should be further studied. Our findings have important implications in understanding the relationship between chemokine receptors and the metastatic potential of HCC.
Keywords:Carcinoma, hepatocellular   Receptor, chemokine   Metastasis, neoplasm   RT-PCR
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号